title: Comment: prophylaxis for RSV hospitalization may not be cost-saving.
authors.forename: Yvonne
authors.initials: Y
authors.lastname: Vergouwe
authors.forename: Ewout W
authors.initials: EW
authors.lastname: Steyerberg
authors.forename: Edwin
authors.initials: E
authors.lastname: Rietveld
authors.forename: Henriëtte A
authors.initials: HA
authors.lastname: Moll
mesh_terms: D003362:Cost-Benefit Analysis / Q000191:economics*; D006760:Hospitalization / Q000191:economics*; D006801:Humans; D007231:Infant, Newborn; D018357:Respiratory Syncytial Virus Infections / Q000191:economics* / Q000517:prevention & control